Resistance to Radiation Enhances Metastasis by Altering RNA Metabolism
Ayush KumariD, Kensei KishimotoiD, Hira Lal Goel, Christi A. Wisniewski, Rui LiiD, Brendan A PachecoiD, Lihua Julie ZhuiD, William A. FlavahaniD, Arthur M. MercurioiD
Abstract
The cellular programs that mediate therapy resistance are often important drivers of metastasis, a phenomenon that needs to be understood better to improve screening and treatment options for cancer patients. Although this issue has been studied extensively for chemotherapy, less is known about a causal link between resistance to radiation therapy and metastasis. We investigated this problem in triple-negative breast cancer (TNBC) and established that radiation resistant tumor cells have enhanced metastatic capacity, especially to bone. Resistance to radiation increases the expression of integrin {beta}3 (ITG{beta}3), which promotes enhanced migration and invasion. Bioinformatic analysis and subsequent experimentation revealed an enrichment of RNA metabolism pathways that stabilize ITG{beta}3 transcripts. Specifically, the RNA binding protein heterogenous nuclear ribonucleoprotein L (HNRNPL), whose expression is regulated by Nrf2, mediates the formation of circular RNAs (circRNAs) that function as competing endogenous RNAs (ceRNAs) for the family of let-7 microRNAs that target ITG{beta}3. Collectively, our findings identify a novel mechanism of radiation-induced metastasis that is driven by alterations in RNA metabolism.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 28%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
Sushmitha Sriramulu, Shivani Thoidingjam, … Shyam Nyati·Journal of Experimental & Clinical Cancer ResearchPeer-reviewed·Jun 11, 2024
- Development of metastases in mice induced by plasma sample collected during radiotherapy in patient with triple-negative breast cancer: Role of Rab4A
Benoît Paquette, Hélène Therriault, … Jean‐Luc Parent·bioRxiv·Jul 23, 2025
- Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation
Steven W. Wall, Karen Wang, … Gloria Vittone Echeverria·bioRxiv·Sep 7, 2026
- Mapping cellular subpopulations within triple negative breast cancer tumors provides a tool for cancer sensitization to radiotherapy
H. Alkhatib, A. M. Rubinstein, … N. Kravchenko-Balasha·bioRxiv·Jan 7, 2021
- lncRNA-WAL Promotes Aggressiveness of Triple-Negative Breast Cancer via inducing β-Catenin nuclear translocation.
Hongyan Huang, Haiyun Jin, … Yan Nie·bioRxiv·Sep 6, 2022
- MNRR1 is required for Triple Negative Breast Cancer growth and metastasis and can be targeted by repurposed drugs.
Mrunal Sathe, Paige M. Minchella, … Siddhesh Aras·bioRxiv·Feb 3, 2026